Peculiarities of blood fibrinolytic activity in patients with comorbidity of chronic pancreatitis and coronary heart disease

Abstract

The article presents the original data indicating changes in the fibrinolytic potential in patients with comorbidity of chronic pancreatitis and coronary heart disease. The results indicate that the increased proteolytic capacity (due to the decreased fibrinolysis) and generalization of the atherosclerotic process, activating chronic DIC-syndrome may be considered as factors aggravating the clinical course of chronic pancreatitis, coronary heart disease and chronic cardiac insufficiency, as they promote the risk of cardiovascular events and ischemic pancreatitis.